Equity · Healthcare
ARGX
argenx SE · NasdaqGS
The line runs $928.11 on 30 June through $960.27 on 25 September, on a scale from $800 to $1,100. Days the market did not trade hold the previous close, flat.
The chart above plots the price of ARGX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $928.11 on 30 June 2026 through $960.27 on 25 September 2026.
Finazon · prior-day close, indicative (IEX-derived, not the official close) · as of Sep 25, 2026
Filings 3 sets
ARGX reported financials
ARGX reported profit loss attributable to owners of parent of $1.3B for the fiscal year ended 31 Dec 2025.
Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025
ARGX institutional holders
8 of the 45 institutional funds we track reported a ARGX position for the quarter ended 30 Jun 2026 — a combined $513.7M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings
ARGX fails-to-deliver
On 27 Aug 2026, 4 shares of ARGX failed to deliver (about $4K) — the latest of 2 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data